Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Peringkat dalam Saham #33689
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Harga Saham
$4.70
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$7.09M
Perubahan (1 hari)
-0.21%
Perubahan (1 tahun)
-70.63%
Negara
US
Perdagangan Apimeds Pharmaceuticals US, Inc (APUS)

Kategori

EPS untuk Apimeds Pharmaceuticals US, Inc (APUS)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham Apimeds Pharmaceuticals US, Inc, EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk Apimeds Pharmaceuticals US, Inc dari 2026 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
Tidak cukup data untuk tanggal yang disediakan.
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE